top of page

Our Services

At your appointment, we provide a FibroScan® assessment of liver health and a proceeding consultation after interpreting the results. The consultation involves discussing the results of the FibroScan® and providing patient education to improve liver health following lifestyle changes. 

The Liver Disease Assessment

The FibroScan® is a non-invasive diagnostic tool we use to measure the amount of fibrosis (scarring) and steatosis (fat) in the liver. It is a non-surgical, efficient, and painless alternative to the traditional liver biopsy. 

A FibroScan® may be used for individuals with the following:

  • Hepatitis B

  • Hepatitis C

  • Alcoholic fatty liver disease (AFLD)

  • Non-alcoholic fatty liver disease (NAFLD)

  • Advanced liver fibrosis (cirrhosis)

  • Hemochromatosis

  • Primary biliary cholangitis (PBC)

  • Autoimmune hepatitis

  • Elevated liver enzymes

  • Increased alcohol intake

  • Methotrexate (MTX)-treated patients

stages of liver disease progression, healthy liver, fatty liver, fibrosis, cirrhosis, liver cancer

The FibroScan®

The FibroScan® uses Vibration-Controlled Transient Elastography (VCTE), a type of ultrasound that uses sound waves to visualize the liver. The results help determine the condition of the liver.

The FibroScan® measures two parameters: liver stiffness (fibrosis) and fat (steatosis). These indicate the scarring of tissues and fat buildup in the liver.  Both of these assessments will be provided at your appointment.

FibroScan Mini+ 430 by Echosens

The Consultation

After interpreting the results of the FibroScan® and assessing the condition of the liver, we share the results with you and follow up with patient education. If you were referred by your doctor, they may decide to receive the results of the FibroScan® and discuss them with you at a later date.

During the consultation, we will discuss lifestyle changes to improve liver health and potentially reverse liver damage for some liver conditions. We may discuss the option to reperform the assessment in about a year to monitor the improvement/progression of the liver disease.

For more information, visit our Frequently Asked Questions.

Book an Appointment

No referral needed. Early identification for early intervention.

bottom of page